Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:46 am Purchase | 2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Adage Capital Management L.P. | 9,602,280 9.300% | 9,602,280 (New Position) | Filing History |
| 2025-02-12 09:45 am Purchase | 2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR | Adage Capital Management L.P. | 599,195 9.860% | 599,195 (New Position) | Filing History |
| 2025-02-12 09:44 am Sale | 2024-12-31 | 13G | Immunic, Inc. IMUX | Adage Capital Management L.P. | 1,398,600 1.550% | -4,195,806 (-75.00%) | Filing History |
| 2025-02-12 09:36 am Purchase | 2024-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Adage Capital Management L.P. | 436,737 5.180% | 436,737 (New Position) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Adage Capital Management L.P. | 1,528,768 3.000% | -801,000 (-34.38%) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Adage Capital Management L.P. | 2,209,615 6.680% | -388,121 (-14.94%) | Filing History |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | UroGen Pharma Ltd. URGN | Adage Capital Management L.P. | 2,928,086 6.940% | -807,655 (-21.62%) | Filing History |
| 2025-02-12 09:33 am Purchase | 2024-12-31 | 13G | DYNAMIX CORP USD DYNX | Adage Capital Management L.P. | 1,350,000 8.130% | 1,350,000 (New Position) | Filing History |
| 2025-02-12 09:33 am Purchase | 2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management L.P. | 5,750,000 8.420% | 1,958,580 (+51.66%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management L.P. | 325,000 9.380% | 106,187 (+48.53%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA | Adage Capital Management L.P. | 3,650,000 6.840% | 3,650,000 (New Position) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management L.P. | 3,000,000 5.560% | 3,000,000 (New Position) | Filing History |
| 2025-02-12 09:31 am Purchase | 2024-12-31 | 13G | Seadrill Limited SDRL | Adage Capital Management L.P. | 3,429,169 5.310% | 3,429,169 (New Position) | Filing History |
| 2025-02-12 09:31 am Purchase | 2024-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Adage Capital Management L.P. | 9,627,304 9.000% | 9,627,304 (New Position) | Filing History |
| 2025-02-12 09:31 am Purchase | 2024-12-31 | 13G | Sitio Royalties Corp. STR | Adage Capital Management L.P. | 6,263,396 7.900% | 6,263,396 (New Position) | Filing History |
| 2025-02-12 09:30 am Purchase | 2024-12-31 | 13G | Protara Therapeutics, Inc. TARA | Adage Capital Management L.P. | 2,250,000 6.560% | 2,250,000 (New Position) | Filing History |
| 2025-02-12 09:30 am Purchase | 2024-12-31 | 13G | Janux Therapeutics, Inc. JANX | Adage Capital Management L.P. | 3,061,750 5.310% | 3,061,750 (New Position) | Filing History |
| 2024-11-19 4:15 pm Purchase | 2024-06-30 | 13G | Zeo Energy Corp. ZEO | Adage Capital Management L.P. | 760,000 5.950% | 760,000 (New Position) | Filing History |
| 2024-11-12 09:40 am Purchase | 2024-09-30 | 13G | MeiraGTx Holdings plc MGTX | Adage Capital Management L.P. | 5,229,099 6.770% | 5,229,099 (New Position) | Filing History |
| 2024-11-12 09:38 am Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | Adage Capital Management L.P. | 3,485,931 3.280% | 3,485,931 (New Position) | Filing History |